Modification of recombinant human epidermal growth factor (rh-EGF) expression vector by site directed mutagenesis for therapeutic protein production

Clicks: 323
ID: 33856
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #36 of 60 articles by views in indonesian journal of biotechnology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Recombinant human epidermal growth factor (rh-EGF) has high value in therapies for h-EGF deficiency related 10 diseases. The recombinant protein was designed to be expressed in pET21b(+) vector using Escherichia coli 11 BL21(DE3) expression host. However, in our previous study, the gene of rh-EGF was constructed aside gene of 12 6xHisTag without any restriction sites, so it is not possible to obtained a purified and single rh-EGF. In this study, 13 we modified the rh-EGF expression vector with a common method, namely site-directed mutagenesis (SDM) to 14 remove the gene of 6xHisTag. The vector modification was carried out by inserting stop codons and EcoR1 15 restriction site, also deleting 6xHisTag sequence with PCR-based SDM. The results of PCR showed non-specific 16 bands, PCR 2-step cycles produced one non-specific band and PCR 3-step cycles produced two non-specific 17 bands. All of the PCR products were purified by gene isolation. The SDM-recombinant plasmids which were 18 treated for template plasmid-free product were transformed to E.coli DH5α. The result of transformation had low 19 transformant efficiency score. However, gene mutation with deletion of 6xHisTag and insertion of stop codons 20 and EcoRI restriction site in plasmid pET21b(+) had been successfully done. In addition, in the expression level, 21 it is proven that the modified vector results rh-EGF which has similar size with rh-EGF standard and 22 approximately 1 kDa smaller than that of our previous rh-EGF-6xHisTag. 23
Reference Key
rodiansyah2019modificationindonesian Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Achmad Rodiansyah;Riyona Desvy Pratiwi;Sabighoh Zanjabila;Asrul M. Fuad;
Journal indonesian journal of biotechnology
Year 2019
DOI
10.22146/ijbiotech.41859
URL
https://jurnal.ugm.ac.id/ijbiotech/article/download/41859/24698
Keywords
recombinant human epidermal growth factor (rh-egf) site-directed mutagenesis (sdm) pet21b(+) escherichia coli bl21(de3)

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.